Related Experiment Videos

CD8(+) T cell responses: it's all downhill after their prime

Joseph N Blattman, Laurence E Cheng, Philip D Greenberg

Nature Immunology

|June 28, 2002

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Dysregulated expression of the tumor suppressor p14ARF in cancer provides an effective target for TCR-T cell therapeutics.

Journal for immunotherapy of cancer·2026

The ubiquitin ligase KLHL6 drives resistance to CD8+ T cell dysfunction.

Nature·2026

Guidelines for T cell nomenclature.

Nature reviews. Immunology·2025

A TGF-βR/IL-2R immunomodulatory fusion protein transforms immunosuppression into T cell activation to enhance adoptive T cell therapy.

Proceedings of the National Academy of Sciences of the United States of America·2025

Triple checkpoint blockade of PD-1, Tim-3, and Lag-3 enhances adoptive T cell immunotherapy in a mouse model of ovarian cancer.

Proceedings of the National Academy of Sciences of the United States of America·2025

A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.

Nature communications·2025

See all related articles